A pill version of semaglutidethe generic name for Novo Nordisks diabetes drug Ozempic and its weight-loss version Wegovywas approved by the Food and Drug Administration as a type 2 diabetes treatment in 2019, but it has largely flown under the radar
Semaglutide The active ingredient in Wegovy and Ozempic The mean change in body weight from baseline to week 68 was -14.9% in the semaglutide group, as compared with -2.4% with placebo. STEP 1, Wilding JPH et al., NEJM 2021;384:989-1002 Tirzepatide The active ingredient in Mounjaro and Zepbound At 72 weeks, the mean percentage change in weight was -20.9% with 15 mg of tirzepatide, as compared with -3.1% with placebo. SURMOUNT-1, Jastreboff AM et al., NEJM 2022;387:205-216 These figures are trial averages for the branded formulations
Any discoloration present before first use is unacceptable and indicates the medication should not be administered
Metabolomics specificity of tuberculosis plasma revealed by (1)H NMR spectroscopy
They regulate blood sugar, preventing spikes that trigger cravings
We understand that one size does not fit all when it comes to weight loss